Online
Cipla
BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | Pharmaceuticals
Buy Cipla, says Sudarshan Sukhani
Buy Cipla, says Technical Analyst, Sudarshan Sukhani....
19-11-2009
19-11-2009: Sudarshan Sukhani's top 5 picks for today's trade
17-11-2009: Cipla has target of Rs 320: Mohindar
11-11-2009: Cipla offers H1N1 virus drug supply to US
11-11-2009: Cipla launches drug to treat H1N1 virus
Cipla
Buy Cipla, target of Rs 370: Hem Securities
Hem Securities has come out with a research report on Cipla. The research firm has initiated a buy signal on the stock with a target price of Rs 370 i...
10-11-2009
04-11-2009: Hold Cipla, target Rs 335: KRChoksey
07-10-2009: Hold Cipla: Indiabulls Securities
28-08-2009: Reduce Cipla, target of Rs 238: Angel
30-07-2009: Buy Cipla, target of Rs 286: KRChoksey
Sudarshan Sukhani's top 5 picks for today's trade
Sudarshan Sukhani of Technical Trends advises investors to buy Allahabad Bank, Cipla, ITC, Rallis India and Ranbaxy Laboratories....
19-11-2009
19-11-2009: Buy Ranbaxy Laboratories: Sukhani
13-11-2009: Buy Sun Pharma; target of Rs 1485: India Infoline
12-11-2009: Ranbaxy gets WHO approval for AIDS drug
12-11-2009: Buy Lupin; target of Rs 1610: IIFL
Peers
Buy Sun Pharma; target of Rs 1485: India Infoline
India Infoline is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 1485, in its November 12, 2009 research report...
13-11-2009
12-11-2009: Buy Lupin; target of Rs 1610: IIFL
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
30-10-2009: Hold Sun Pharma; target of Rs 1422: Sharekhan
29-10-2009: Dr Reddy's Labs an outperformer, target of Rs 1200: Karvy
21-11-2009: Sensex ends in positive; banks, metal gainFriday, November 20, 2009,10:21 [IST]
19-11-2009: Nifty ends below 5k mark; metal, telecom dipThursday, November 19, 2009,10:16 [IST]
19-11-2009: Nifty trading with negative bias; HCL, Unitech dipThursday, November 19, 2009,10:16 [IST]
18-11-2009: Sensex ends marginally lower; SBI, ICICI dipWednesday, November 18, 2009,10:24 [IST]
18-11-2009: India Inc discovers the power of two
17-11-2009: India, Canada to ink civil N-deal soon
14-11-2009: Cipla launches generic drugs for swine flu treatment
12-11-2009: Cipla launches Antiflu to treat Swine Flu Virus
12-11-2009: Buying across sectors help mkts end higherWednesday, November 11, 2009,10:16 [IST]
12-11-2009: Jubilant runs out of steam on St
12-11-2009: Cipla unveils drug to combat H1N1 virus
11-11-2009: Cipla launches swine flu drug
11-11-2009: Cipla offers H1N1 virus drug supply to US
11-11-2009: Mkts open weak; realty and telecom trading in redWednesday, November 11, 2009,10:16 [IST]
11-11-2009: Cipla launches drug to treat H1N1 virus
11-11-2009: Painting a new path
11-11-2009: Market ends lower on profit-taking, Nifty down by 17 pts
10-11-2009: Mkts break 4-day rally and shut shop lowerTuesday, November 10, 2009,10:16 [IST]
10-11-2009: Nifty slips in red; Hero Honda, HUL, DLF down
10-11-2009: Emergency pills to maintain OTC drug status
19-11-2009: Sensex sheds 213 points on profit booking
18-11-2009: Sensex breaks the 3-day winning streak
18-11-2009: Sensex ends marginally lower; SBI, ICICI dipWednesday, November 18, 2009,10:24 [IST]
18-11-2009: Sun Pharma gets us nod for lukaemia drug
16-11-2009: India Inc gets into bear hug with Russian consumers
14-11-2009: India Inc gets into bear hug with Russian consumers
03-11-2009: EU seizes another generic package
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
19-11-2009: Nifty ends below 5k mark; metal, telecom dipThursday, November 19, 2009,10:16 [IST]
19-11-2009: Nifty trading with negative bias; HCL, Unitech dipThursday, November 19, 2009,10:16 [IST]
14-11-2009: Bulls push Sensex up 4.2 percent
14-11-2009: Bulls push Sensex up 4.2 percent
21-11-2009: Did U.S. make mistake in skipping vaccine additive?
21-11-2009: Canada to have vaccine soon for half population
20-11-2009: Glaxo, Merck developing drugs for kala azar
19-11-2009: Soon, a vaccine to help quit smoking
12-11-2009: Jubilant runs out of steam on St
12-11-2009: 'E7' the new El Dorado for pharma
08-11-2009: Recovery tempered by challenges
06-11-2009: NSE's stock options trade fails to mirror revival
